Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Vehicle-controlled, Parallel, Phase III Study to Evaluate Efficacy and Safety of ENERGI-F703 GEL in Subjects With Diabetic Foot Ulcers
Conditions
Interventions
ENERGI-F703 GEL
ENERGI-F703 matched vehicle
Locations
24
United States
A and D Doctor Center
Miami, Florida, United States
Bioclinical Research
Miami, Florida, United States
Reliant Medical Research
Miami, Florida, United States
Advanced Medical Research Institute
Miami, Florida, United States
New Horizons Research
Palmetto Bay, Florida, United States
IACT Health
Columbus, Georgia, United States
Start Date
May 30, 2023
Primary Completion Date
December 30, 2025
Completion Date
March 31, 2026
Last Updated
October 2, 2025
NCT06383013
NCT07541196
NCT07224321
NCT07232537
NCT07536516
NCT07340320
Lead Sponsor
Energenesis Biomedical Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions